Your session is about to expire
← Back to Search
Sleep Extension for Type 1 Diabetes (FREADOM Trial)
FREADOM Trial Summary
This trial is to see if extending sleep can help manage diabetes in youth.
FREADOM Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowFREADOM Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.FREADOM Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a condition that would make it hard for you to sleep or take part in the study, according to the main doctor in charge.You have type 1 diabetes.
- Group 1: Sleep Extension
- Group 2: Routine
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this experiment accommodate participants aged forty or above?
"Consistent with the trial requirements, the participant pool is limited to minors aged 10-17."
What is the upper limit of participants enrolled in this experiment?
"Affirmative. According to clinicaltrials.gov, this research has been opened for recruitment since September 15th 2017 and was last updated on June 29th 2022. 175 test subjects are needed from 2 different medical facilities."
Is there an opportunity for me to participate in the trial?
"Applicants must suffer from diabetes mellitus and be between 10 and 17 years old in order to join this clinical trial. A total of 175 candidates are sought by the research team."
Are there any openings remaining in this clinical experiment?
"Affirmative, this clinical trial is actively enrolling participants. The study was initially listed on September 15th 2017 and last updated June 29th 2022. 175 people located at 2 sites are required to complete the research project."
Share this study with friends
Copy Link
Messenger